|
The initial reporter questioned the results for 1 patient tested for elecsys brahms pct (pct) on a cobas e 402 analytical unit.The patient was tested daily with results consistently around 2 ng/ml (examples provided were 1.89 ng/ml and 2.11 ng/ml).The results were "always repeatable." the following specific results were provided: on (b)(6) 2025, the result was 2.22 ng/ml.On (b)(6) 2025, the result was 2.49 ng/ml.On (b)(6) 2025, the result was 1.94 ng/ml.On (b)(6) 2025, the result was 2.08 ng/ml.On (b)(6) 2025, the result was 2.18 ng/ml.On (b)(6) 2025, the result was 1.87 ng/ml.On (b)(6) 2025, the result was 2.09 ng/ml.On (b)(6) 2025, the result was 2.09 ng/ml.On (b)(6) 2025, the result was 2.08 ng/ml.On (b)(6) 2025, the result was 2.21 ng/ml.On (b)(6) 2025, the result was 1.91 ng/ml.The patient had been initially tested by a mindray instrument, which produced similar results.A sample from the patient was tested at an external laboratory using the vidas method, and the result was also "positive" (1.27 ng/ml).The pct results are in question as no other test results suggest sepsis, the patient is well with no fever, and the crp result was "negative." the customer suspects an interference affecting the results.
|